All In MedTech

FDA Clearance Tracker · P130029-S004

FLUENCY PLUS ENDOVASCULAR STENT GRAFT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 24, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 24, 2016

Approved

Time to decision

194 days

Received Feb 12, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130029-S004
Device name
FLUENCY PLUS ENDOVASCULAR STENT GRAFT
Applicant location
Tempe, AZ
Received
Feb 12, 2016
Decided
Aug 24, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P130029

Device type

Device class
Class III

Every decision under product code PFV

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Sterigenics Belgium Petit-Rechain S.A., Zoning Industriel de petit-Rechain, Avenue Andre Ernst 21, Petit-Rechain, Verviers, 4800, Belgium, for contract sterilization.

Source documents

Other decisions for Bard Peripheral Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.